Literature DB >> 6571437

The NMR diagnosis of cerebral tumors.

G M Bydder, J M Pennock, R E Steiner, J S Orr, D R Bailes, I R Young.   

Abstract

The results of NMR examinations in 52 patients with histological or clinical diagnoses of cerebral tumor are reviewed. An increase in relaxation time was recognized in all tumors but problems were experienced in distinguishing the margin of tumors from surrounding edema. Mass effects were well demonstrated as a result of the high level of gray-white matter contrast available with inversion-recovery sequences and the use of coronal and sagittal imaging planes. In general repeated FID sequences were less sensitive in detecting tumors than inversion-recovery or spin-echo sequences. Periventricular edema was well demonstrated with spin-echo sequences and was of importance in recognizing acute or subacute hydrocephalus. Radiation therapy was associated with increased relaxation times particularly within white matter. Problems in the recognition of tumor recurrence following treatment are outlined. The opportunities and challenges that NMR imaging is now providing for physicists and radiologists are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6571437     DOI: 10.1002/mrm.1910010105

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  [Contrast in static images in clinical magnetic resonance imaging : Part 1: Contrast properties of tissue].

Authors:  F Schick
Journal:  Radiologe       Date:  2013-05       Impact factor: 0.635

Review 2.  The transoral approach to the base of the brain and upper cervical cord.

Authors:  H A Crockard
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

3.  Variation of the magnetic relaxation rate 1/T1 of water protons with magnetic field strength (NMRD profile) of untreated, non-calcified, human astrocytomas: correlation with histology and solids content.

Authors:  M Spiller; S S Kasoff; T A Lansen; S Rifkinson-Mann; M P Valsamis; S H Koenig; M S Tenner
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.